APEX-STROKE EAGLE Domain (EAGLE)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 878 participants.

Also called NCT07790354

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 878 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07790354
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07790354. Randomized; single masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
APEX-STROKE EAGLE Domain (EAGLE)
Acronym
EAGLE
Condition
Stroke
Condition
Intracerebra Hemorrhage
Intervention (Other)
Early surgical bundle
Intervention (Other)
Guideline-Based Standard Care
Lead sponsor
Fudan University (class: other)
Collaborator
Huashan Hospital (class: other)
Collaborator
First Affiliated Hospital of Fujian Medical University (class: other)

Record details

Record id
cardio:ct-nct07790354
Content hash
9ece3bc35190043be45557bb1f34ec40e0bbb6e8c3b70e9541b9a0d7a31442fe